Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04495153
Title GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Candel Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
UConn Health Farmington Connecticut 06030 United States Details
Yale University, Yale Cancer Center New Haven Connecticut 06510 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Maryland, Baltimore Baltimore Maryland 21201 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
NYU Langone Health New York New York 10016 United States Details
The Ohio State University Wexner Medical Center Columbus Ohio 43210 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Utah Salt Lake City Utah 84112 United States Details
Hunter Holmes McGuire VA Medical Center Richmond Virginia 23249 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field